Martingale Asset Management L P Cytom X Therapeutics, Inc. Transaction History

Martingale Asset Management L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$6.33 - $9.91 $106,514 - $166,755	-16,827 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$6.6 - $9.0 $111,058 - $151,443	16,827 New	16,827 $130,000
Q4 2020 Feb 10, 2021	SELL	$6.47 - $7.9 $643,266 - $785,441	-99,423 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$6.55 - $8.83 $217,414 - $293,094	-33,193 Reduced 25.03%	99,423 $661,000
Q2 2020 Aug 10, 2020	BUY	$7.4 - $14.64 $981,358 - $1.94 Million	132,616 New	132,616 $1.1 Million

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.